Evaluation of a 25-Year-Program for the Control of Schistosomiasis Mansoni in an Endemic Area in Brazil

A clinical-epidemiological reevaluation on schistosomiasis mansoni was performed in 2005, in the urban area of a little town, Comercinho, MG, specifically focusing on the inhabitants of the same area in 1981, when a first survey and treatment with oxamniquine were carried out. The surveys included: identification of the intermediary host, census, mapping of the city, socioeconomic survey, stool examination, clinical examination, research dealing with contact with natural waters, and treatment of the positive cases. From a population of 1,474 people studied in 1981, 358 were submitted to stool examination, and 231 were clinically examined. From 1981 to 1992 five specific treatments were performed with oxamniquine and the last one with praziquantel. The results obtained were compared and demonstrated that the prevalence in Comercinho decreased significantly (70.4% to 1.7%), as well as the hepatosplenic form (7% to 1.3%) in 1981 and 2005, respectively. Significant improvement in the life quality (improvement in the housing, professional qualification and basic sanitation) were observed and must be considered important for the schistosomiasis control

Relato de caso de Lagochilascariose humana procedente do Estado do Pará, Brasil Report a case of human lagochilascariasis coming from the Pará State, Brazil

Mais um caso de lagochilascariose em criança procedente do Município de Xinguara PA. No Hospital das Clínicas da UFG, foi feita drenagem do abscesso localizado na região cervical direita, constatando-se a presença de ovos e vermes adultos de Lagochilascaris minor. Instituída terapia com albendazol 400mg/dia (durante 30 dias) e antibioticoterapia, houve regressão do quadro clinico.<br>A new case of lagochilascariasis is reported in a child from Xinguara PA, Brazil. The patient had an abscess in the right cervical region, which was drained at the Clinical Hospital of UFG. Eggs and adult stages of Lagochilascaris minor were found in the secretion of the abscess. Treatment with albendazol, at a dosage of 400mg/day for 30 days, associated with antibiotics promoted regression of the lesion